If you're reading this, then odds are you already know shipping stocks like Diana Shipping Inc. (NYSE:DSX), Safe Bulkers, Inc. (NYSE:SB), and Navios Maritime Partners L.P. (NYSE:NMM) are all up big-time today, and up nicely for the week, for that matter. SB is up 11% for the day, NMM is up 6% for the week, while DSX is higher by 8% for the session, snapping a surprisingly-long weak streak.
You nay even know why picks like Navios Maritime Partners L.P., Safe Bulkers, and Diana Shipping are up so firmly today, or up so well for the past few days - the Baltic Dry Index has rallied quite nicely this week. Since the Baltic Dry Index is a measure of the daily charter rates that shipping vessels are charging (not how much they'd like to get for a charter, but how much they're actually inking deal for) companies that need to get goods from point A to point B, one can only presume higher rates - and a fairly static supply - means demand is starting to swell. That's a positive for stocks like NMM, SB, and DSX.
Hot Shipping Companies To Own For 2015: Nintendo Co Ltd (NTDOY)
Nintendo Co., Ltd. is a Japan-based company mainly engaged in the leisure machine business. The Company operates in two business segments. The Leisure Machine segment is engaged in the development, manufacturing and sale of portable and console game machines as well as game software. The Others segment is engaged in the manufacture and sale of poker cards and karuta (Japanese-style playing cards), the sale of Pokemon (a Japanese animation character) goods, the management of intellectual property rights and the provision of electronic registration services of home use console machines, among others.
Advisors' Opinion:- [By Rick Munarriz]
Clearly Microsoft has done just fine with its army of Web-tethered individuals. Microsoft's presentation also makes it clear that it will once again be the one to beat this generation. Sony (NYSE: SNE ) -- whose upcoming PlayStation 4 will butt heads with Microsoft's new toy later this year -- won't catch up. Nintendo (NASDAQOTH: NTDOY ) -- whose interactive, family-oriented games would seem to make it a better heir for the living room throne -- didn't make much of a dent with the Wii U last November when it entered the holiday shopping season uncontested. It will be toast this time around.
Hot Shipping Companies To Own For 2015: Roche Holding AG (RHHBY)
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. The Company belongs to the Roche Group that operates through numerous subsidiaries and associated companies located around the world. The Company�� products and services cover every stage of the healthcare process, from identifying disease susceptibilities and testing for disease in at-risk populations to prevention, diagnosis, therapy and treatment monitoring. Roche operates through two divisions: Pharmaceuticals and Diagnostics. Within the Pharmaceuticals Division there are three sub-divisions: Roche Pharmaceuticals, Genentech and Chugai. The Company�� Diagnostics Division includes five sub-divisions: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. Its activities are structured into six geographical segments: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan. In March 2009, the Company completed the acquisition of Genentech, Inc. In March 2010, the Company acquired assets from BioMicro Systems for all products associated with the Roche NimbleGen microarray workflow.
During the year ended December 31, 2008, the Company Pharmaceuticals Division marketing gained approvals for its rheumatoid arthritis medicine Actemra/RoActemra in Japan, Switzerland and the European Union. In 2008, the division initiated 12 new phase III projects in, including clinical trials of the compounds pertuzumab, for breast cancer; taspoglutide, for type two diabetes, and dalcetrapib, for cardiovascular risk reduction. As of December 31, 2008, the Pharmaceuticals Division filed 11 major new marketing applications and gained 13 major regulatory approvals. At the beginning of 2009, the division�� research and development pipeline comprised 120 clinical projects, including 62 new molecular entities (NMEs) and 58 additional indications. Forty NMEs are in phase I, 16 in phase II and six in phase III or f! iled for regulatory review.
In 2008, Roche Pharmaceuticals signed a total of 57 new agreements including seven product transactions and 43 research and technology collaborations. In May 2008, Roche acquired Piramed Limited, a UK company with therapeutic research programmes targeting the PI3-kinase pathway in oncology and inflammatory disease. In June 2008, signed licensing agreement with ThromboGenics and BioInvent for their jointly developed anticancer agent TB-403 (R7334). In September, 2008, the Company acquired Mirus Bio Corporation active in the field of ribonucleic acid interference (RNAi) delivery and completed the acquisition of ARIUS Research Inc., which has a antibody platform that identifies and selects antibodies based on their functional ability to affect disease. S Research Inc. In January 2009, Roche acquired Memory Pharmaceuticals, which develops drug candidates for the treatment of debilitating central nervous system disorders such as Alzheimer�� disease and schizophrenia.
Pharmaceuticals
Within Pharmaceuticals division, the Company is engaged in the provision of drugs the areas of oncology, anemia, cardiovascular diseases, central nervous system, infectious diseases, inflammatory and autoimmune diseases, metabolic disorders, cancer, transplantation and virology. The products offered by Roche�� Pharmaceuticals division include MabThera/Rituxan, Herceptin, Avastin, Tamiflu, CellCept, NeoRecormon, Epogin, Pegasys, Tarceva, Xeloda, Bonviva, Boniva, Lucentis, Tamiflu, Xolair, Valcyte, Cymevene, Xenical, Pulmozyme, Nutropin, Neutrogin, Rocephin, Activase, TNKase and Madopar. The products offered by the Pharmaceuticals division are sold in seven geographic regions: North America; Asia-Pacific; Western Europe; Latin America; Central and Eastern Europe, Middle East and Africa (CEMAI), and Japan.
Diagnostics
Roche�� Diagnostics Division is a supplier of in vitro diagnostics (IVDs). Its products are used to test body fluids a! nd tissue! samples to obtain information for the purpose of preventing, diagnosing, treating and monitoring disease. The Company has business areas five within the diagnostics division: Professional Diagnostics, Diabetes Care, Tissue Diagnostics, Molecular Diagnostics and Applied Science. Roche�� Diagnostics division provides IVD services, including centralized laboratory testing and point-of-care diagnostics to molecular diagnostics and diabetes self management. In addition, it supplies research tools to life scientists.
Roche Professional Diagnostics supplies instrument systems, tests, software and services. It provides point-of-care testing products to support clinical decision-making close to the patient, in doctors��offices, emergency rooms and other primary and specialty care settings. Twelve Serum Work Area assays were rolled out during the year ended December 31, 2008, across Europe and in other markets. New assays included the Elecsys anti-TSH receptor antibody assay for the diagnosis of Graves��disease the Elecsys anti-CCP antibody assay, a test to aid the diagnosis of rheumatoid arthritis, and the Roche Cystatin C clinical chemistry test for early detection of impaired kidney function, among others. Roche Diabetes Care�� products portfolio covers the entire diabetes self-management spectrum, from glucose monitoring to insulin delivery, as well as monitoring systems with integrated lancets and test strips software for storing and analyzing data. Roche Tissue Diagnostics develops and manufactures medical diagnostic instruments and reagent systems that provide automation technology for use in the diagnosis and prognosis of cancer and infectious disease. In 2008 Roche Tissue Diagnostics launched ofhe Bench- Mark Ultra, a system that performs immunohistochemistry and in situ hybridisation testing simultaneously on a single continuous and random access platform. Roche Molecular Diagnostics develops and commercializes diagnostic and blood screening platforms and tests based on Roche�� ! real-time! polymerase chain reaction (PCR) technology. Applied Science business area supplies a specific reagents and test kits for use in life sciences encompassing biology, biotechnology ,medical research, as well as disease areas like cancer and virology. Applied Science�� business area product portfolio includes such sequencing systems as LightCycler 480, LightCycler 480 II, GS FLX Titanium. In addition, Applied Science offers xCELLigence cell analyzer.
Advisors' Opinion:- [By Brian Orelli]
Bristol is testing its combination in lung and renal cancers, and one of its competitors, Roche (NASDAQOTH: RHHBY ) , which has a drug called MPDL3280A that works in the same pathway, has shown that its drug can work in six different types of cancer.
- [By Dimitra DeFotis]
There are two cancer vaccines on the market: Provenge, a prostate-cancer treatment from Seattle-based Dendreon�(DNDN), and Yervoy, a melanoma treatment from Bristol-Myers Squibb�(BMY), according to Dow Jones Newswires. In May, Roche�Holding (RHHBY) said its experimental cancer vaccine, called MPDL3280A, shrank tumors in 21% of 140 patients participating in a trial. It is now performing tests in lung cancer patients.
- [By George Budwell]
Will BioMarin be the next orphan drugmaker to be bought out?
Over the last decade, BioMarin Pharmaceutical (NASDAQ: BMRN ) has become one of the top orphan drug specialists, making it a frequent visitor to the buyout rumor mill. Roche (NASDAQOTH: RHHBY ) was previously named as an interested party, but the company's CEO squashed that rumor, saying BioMarin was too expensive. - [By Dan Carroll]
First off, the melanoma drug market isn't huge -- yet. Research firm Decision Resources said last year that Roche's (NASDAQOTH: RHHBY ) Zelboraf and Bristol-Myers Squibb's (NYSE: BMY ) Yervoy, two immunotherapies approved in 2011 to treat melanoma, accounted for two-thirds of the malignant melanoma drug market. Yervoy picked up more than $700 million in sales last year, but Zelboraf only recorded around $250 million in revenue. That's not a giant market to capitalize on.
Top Semiconductor Companies To Own In Right Now: Greengro Technologies Inc (GRNH)
GreenGro Technologies Inc., formerly Authoriszor Inc., provides management services for the planning, construction, staffing and operation of medical marijuana dispensaries, and nurseries on behalf of non-profit patient co-operatives. Through long term contracts, the Company operates non-profit centers, returning all unused patient contributions, on a pro-rata basis to each co-op member in the form of additional product. In February 2010, Authoriszor Inc. completed the acquisition of GreenGro Technologies, Inc., and CannovaHealth, a clinic management company. In September 2011, the Company acquired Vertical Hydrogarden, Inc.
Medical marijuana (medical cannabis) is an alternative method to other forms of medication used to manage or alleviate pain without the undo side-effects caused by the prescription medication being used to treat an illness. The Company stands ready to assist in patient care co-operatives throughout the United States.
Advisors' Opinion:- [By James E. Brumley]
If it seems like the buzz surrounding marijuana stocks like Medical Marijuana Inc. (OTCMKTS:MJNA), Hemp, Inc. (OTCMKTS:HEMP), and GreenGro Technologies, Inc. (OTCMKTS:GRNH) has been a little louder than usual the last few days, you're not crazy - it has been louder, and particularly bullish. GRNH shares advanced 37% in December. HEMP is up 166% for the past two weeks. MJNA has jumped 47% in just the past couple of days. Well, as it turns out, it's not just mere coincidence that GreenGro Technologies, Hemp, Medical Marijuana, and a bunch of other cannabis-related names have perked up of late. And, odds are pretty good they'll all continue to do well (even of the pace slows a bit) in 2014.
- [By Ben Levisohn]
But, as the Huffington Post points out, most of the companies that stand to benefit are very small–they make micro caps look big–trade over the counter–good bye liquidity. That includes transaction-processing company MediSwipe (MWIPD), GreenGro Technologies (GRNH) Medbox (MDBX), which makes dispenser for high-risk drugs, and GW Pharmaceuticals (GWPRF).
Hot Shipping Companies To Own For 2015: Leggett & Platt Incorporated(LEG)
Leggett & Platt, Incorporated designs and produces various engineered components and products worldwide. Its Residential Furnishings segment offers bedding components, such as innersprings and wire forms; furniture components, including steel mechanisms, springs, seat suspensions, steel tubular seat frames, bed frames, ornamental beds, and power foundations; and structural fabrics, carpet underlay materials, and geo components. This segment serves manufacturers of finished bedding products or upholstered furniture. The company?s Commercial Fixturing & Components segment provides shelving, counters, showcases, and garment racks; standardized shelvings; point-of-purchase displays; and bases, columns, back rests, casters, and frames. This segment offers its products to retail chains and specialty shops; brand name marketers; distributors of consumer products; and office, institutional, and commercial furniture manufacturers. Its Industrial Materials segment provides steel rod s, drawn wires, steel billets, fabricated wire products, welded steel tubing, and fabricated tube components to bedding and furniture, and mechanical spring makers; automotive seating, and lawn and garden equipment manufacturers; and waste recyclers, waste removal businesses, and medical supply businesses. The company?s Specialized Products segment offers manual and power lumbar support and massage systems; seat suspension systems; automotive control cables; low voltage motors; actuation assemblies; formed metal and wire components; quilting machines; machines for shaping wire into springs; industrial sewing/finishing machines; van interiors; and docking stations, as well as specialty trailers for telephone, cable, and utility companies. It serves bedding and automobile seating manufacturers. The company sells its products through its sales representatives and distributors. Leggett & Platt, Incorporated was founded in 1883 and is based in Carthage, Missouri.
Advisors' Opinion:- [By Dividends4Life]
Linked here is a detailed quantitative analysis of Leggett & Platt Inc. (LEG). Below are some highlights from the above linked analysis:
Company Description: Leggett & Platt Inc. makes a broad line of bedding and furniture components and other home, office and commercial furnishings, as well as products for non-furnishings markets.
Hot Shipping Companies To Own For 2015: Brown(n)
N Brown Group plc operates as an Internet and catalogue home shopping company in the United Kingdom. The company principally offers womenswear, menswear, footwear, household, and electrical products, as well as provides insurance services. It also operates in the Republic of Ireland, Germany, and the United States. The company was founded in 1859 and is based in Manchester, the United Kingdom.
Advisors' Opinion:- [By Rich Duprey]
NetSuite� (NYSE: N ) �plans to offer $270 million worth�of its convertible senior notes due 2018 to qualified institutional buyers, with the�initial purchasers getting an option to buy up to�$40 million�more solely to cover overallotments.�
- [By Lee Jackson]
NetSuite Inc. (NYSE: N) is the industry’s leading provider of cloud-based financials and omnichannel commerce suites. The company drives earnings growth with a subscription-based business model gives businesses a new way to sell services and products that can result in more predictable revenue streams. The consensus price target for the stock is $91.
- [By David Trainer]
Cloud software provider Callidus (NASDAQ: CALD) is in the Danger Zone this week. We’ve recently highlighted two other Software as a Service (SaaS) companies in Netsuite (NYSE: N) andSalesforce.com (NYSE: CRM), and CALD is a classic story of a bad company riding the coattail of the popularity of cloud computing and SaaS companies. SaaS stocks surged in 2013, and CALD followed the trend, gaining 166% over the past year.
Hot Shipping Companies To Own For 2015: Weingarten Realty Investors(WRI)
Weingarten Realty Investors operates as a real estate investment trust (REIT). The company engages in the management, acquisition, and development of real estate. It operates in two segments, Shopping Center and Industrial. The Shopping Center segment engages in the acquisition, development, and management of real estate, primarily anchored neighborhood and community shopping centers located in Texas, California, Louisiana, Arizona, Nevada, Arkansas, New Mexico, Oklahoma, Tennessee, Kansas, Colorado, Missouri, Illinois, Florida, North Carolina, Mississippi, Georgia, Utah, Kentucky, and Maine. Its customer base includes supermarkets, discount retailers, drugstores, and other retailers. The Industrial segment engages in the acquisition, development, and management of bulk warehouses and office/service centers. Its properties are located in Texas, Nevada, Georgia, Florida, California, and Tennessee. As of June 30, 2005, Weingarten Realty Investors owned or operated under long -term leases, directly or through its interest in joint ventures or partnerships, a total of 350 developed properties and 3 properties that are in various stages of development. Its properties include 294 shopping centers and 59 industrial properties. Weingarten Realty Investors qualifies as a REIT for federal income tax purposes. As a REIT, it would not be taxed on the portion of its income, which is distributed to shareholders, provided it distributes at least 90% of its taxable income. The company was founded in 1948 and is based in Houston, Texas.
Advisors' Opinion:- [By Marc Bastow]
Shopping center real estate investment trust (REIT) Weingarten Realty (WRI) raised its quarterly dividend 6.6% to 32.5 cents per share, payable March 14 to shareholders of record as of March 6.
WGI Dividend Yield: 4.32%
No comments:
Post a Comment